Equity
€311,654 ▲ 16.5%
UMANIMO has made a profit in every financial year since 2019.
UMANIMO
Lifetime
7 annual accounts with figures on one time axispeak €630,377 (2024)
€440,433▼ 30.1%
peak €261,214 (2021)
€44,046▼ 80.4%
peak €311,654 (2025)
€311,654▲ 16.5%
€469,936▲ 27.0%
peak 8.6 FTE (2025)
8.6 FTE▲ 4.9%
Board8 names since 2019
5 directorsDu Bois Joli and 4 others
Owners2 names in the annual accounts
21.11%TRIMOTTET and 1 other
Documentsfilings and deeds
26-06-202635 days before the deadline
2025abbreviated format
Gross margin from €630,377 to €440,433Result from €224,842 to €44,046Appointments: NIFIVET SRL (director) and BALZAT SRL (director) 05-05Equity from €267,608 to €311,654Debts from €370,154 to €469,936Cash from €115,030 to €349,173
Key points
from the 2025 annual accountsResult
€44,046 ▼ 80.4%
The result fell in 2025: different schema filed.
Turnover
≈ €1.0m estimated
The accounts state no turnover.
Debts
€469,936 ▲ 27.0%
Debts rose by €99,782 in 2025.
Staff
9 employees on 31-12-2025
In 2025, 7 people joined and 14 left.
Filings
7 annual accounts since 2019
The last five annual accounts were filed 0 to 140 days before the end of the period.
Checked score
93
Excellent
Financially stronger than 47% of micro companies in veterinary activities (NACE 75)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 1,971 companies (NACE 75, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.2%▲ +0.1 percentage points vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.2%● unchanged vs 06-2025
08-2025: 0.4%▲ +0.2 percentage points vs 07-2025highest value
09-2025: 0.1%▼ -0.3 percentage points vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026lowest value
08-2026: 0.1%● unchanged vs 07-2026lowest value
09-2026: 0.1%● unchanged vs 08-2026lowest value
10-2026: 0.1%● unchanged vs 09-2026lowest value
11-2026: 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
lowers risk
Sector: Veterinary activities (NACE 75)
Liquidity: current ratio 1.61, cash €349,173
Figures for financial year 2025 (filed on 26-06-2026)
Equity €311,654 (39.9% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 75, micro). It does better than 40% of them on solvency, 63% on liquidity, 27% on profitability and 56% on growth.
The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 26,972 companies had the same profile as UMANIMO has now. Each dot stands for 68 companies, two years later.
94.9%
were still trading
3.4%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of UMANIMO itself is lower: 0.1% within 12 months. It rests on far more data about UMANIMO than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,972 companies, not a prediction for UMANIMO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.61 (1.68 in 2024), above the usual 1.5. Short-term debt is 50.3% and cash 44.7% of total assets. However, 60.1% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
6 signals, none raises the risk
Six signals.
lowers riskneutral
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
19202122232425
2019 to 2025 · latest year €311,654
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
35 days early
2024
on the day
2023
140 days early
2022
66 days early
2021
135 days early
2020
107 days early
2019
28 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 73 days before the deadline. In the sector (NACE 75), the median for financial year 2024 was 6 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 May (4 of the last 5 accounts filed within 69 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- TRIMOTTET 21.11%score 94equity €434,244 (2025) · 2025 annual accounts of TRIMOTTET
- MAXIVET 20%score 86equity €47,646 (2025) · 2025 annual accounts of MAXIVET
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0735643050
Appointments: NIFIVET SRL (director) and BALZAT SRL (director)
General meeting of 25-03-2025 · Gazette deed
2 directors appointed, 3 resignations
Resignations: Michel SCHOFFENIELS, Selim SOLTANI and Yvan SCHOUBEN · Appointments: DU BOIS JOLI and MAXIVET · Permanent representatives: Selim SOLTANI, Yvan SCHOUBEN and Lionel SIMON · General meeting of 19-12-2022 · Gazette deed
Permanent representative: Lionel SIMON
General meeting of 13-12-2021 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| UMANIMO Fléron | €0.8m | €440,433 | 39.9% | 8.6 |
| Venhei Health Service Kasterlee | €0.7m | €577,992 | 44.1% | 10.5 |
| ARVETIA Bastogne | €0.6m | €473,945 | 20.5% | 6.7 |
| Via Nova Equine Services Bree | €1.1m | €614,855 | -29.2% | 8.2 |
| VETENAC Héron | €0.9m | €652,254 | 10.6% | 10.7 |
| VETLIFE Braine-l'Alleud | €1.3m | €563,591 | 34.6% | 5.8 |
| NIV-VET Nivelles | €1.6m | €642,251 | 16.7% | 9.8 |
These companies have the same main activity as UMANIMO: veterinary services (NACE 75000). They are comparable in size and age: total assets between €634,000 and €1.6m, founded between 2015 and 2022.
Official details
Source: KBO- Status
- Active since 03-10-2019Normal situation
- Activity
- Veterinary servicesNACE 75000
- Joint committee
- 336Liberal professions · annual accounts 2022
- Establishment units
- 2.294.814.5184620 Fléron, since 03-10-2019
- 2.294.815.2114620 Fléron, since 03-10-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 18-11-2025
Annual accounts 2025
- €781,590▲ 22.6%
- Employeeson 31-12-2025
- 9=
- Filing
- Filed on 26-06-2026, 35 days before the end of the filing period
Insights on UMANIMO
UMANIMO files the abbreviated format. That format states no turnover. The gross margin rose from €217,297 in 2019 to €440,433 in 2025.
In 2022, three directors stepped down.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about UMANIMO
- What is the company number of UMANIMO?
- The company number of UMANIMO is 0735.643.050. The VAT number is the same number with BE in front: BE 0735.643.050.
- Where is UMANIMO based?
- The registered office is at Rue du Fond du Flo 30, 4621 Fléron.Company details
- What does UMANIMO do?
- According to the KBO register, the main activity is veterinary services (NACE 75000).
- What is the legal form of UMANIMO?
- UMANIMO is a private limited company (BV).
- When was UMANIMO founded?
- UMANIMO was founded on 03-10-2019.
- Is UMANIMO still active?
- Yes, UMANIMO is an active enterprise in the KBO register.
- How many employees does UMANIMO have?
- UMANIMO had an average of 8.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does UMANIMO fall under?
- In its 2022 annual accounts, UMANIMO states joint committee 336 (Liberal professions).
- What is the turnover of UMANIMO?
- The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €440,433 and 2,275 comparable companies of the same size. It probably lies between €620,000 and €1.8m. It is a rough estimate.
- Is UMANIMO profitable?
- In financial year 2025, UMANIMO made a profit of €44,046.
- Where can I find the annual accounts of UMANIMO?
- UMANIMO filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of UMANIMO due?
- UMANIMO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.